These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8720582)

  • 21. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants.
    Martin KF; Phillips I; Hearson M; Prow MR; Heal DJ
    Br J Pharmacol; 1992 Sep; 107(1):15-21. PubMed ID: 1422568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
    Berrocoso E; Mico JA
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of 5-HT1A receptors in the antinociceptive action of 8-hydroxy-2-(di-n- propylamino)tetralin in the rat.
    Cervo L; Rossi C; Tatarczynska E; Samanin R
    Eur J Pharmacol; 1994 Sep; 263(1-2):187-91. PubMed ID: 7821351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
    Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Rabin RA; Winter JC
    Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
    Ocaña M; Barrios M; Baeyens JM
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
    Bervoets K; Millan MJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of (R)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on the monosynaptic spinal reflex in rats.
    Honda M; Ono H
    Eur J Pharmacol; 1999 Jun; 373(2-3):171-9. PubMed ID: 10414436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
    Amarante LH; Alves DP; Duarte ID
    Eur J Pharmacol; 2004 Jun; 494(2-3):155-60. PubMed ID: 15212969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA; Chou JM; Tang H; Frazer A
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
    Alhaider AA; Wilcox GL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):378-85. PubMed ID: 7682614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.